COVID-19 Vaccines | Cervical Cancer Surgery | Big Data, Cancer Information Highlights, 06/09/2021

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI COVID-19 Vaccines May Be Less Effective in Some People with Cancer   People with blood cancers seem less protected by COVID-19 vaccines than people with other cancers and people without cancer, three new studies suggest. Experts believe this lack of protection is likely due to their weakened immune systems. Fewer People with Early-Stage Cervical Cancer Are Having Minimally Invasive Surgeries   The shift toward fewer minimally invasive surgeries, including robotic surgery, follows the release of results from a 2018 study that found open surgeries had better results. Speeding Up Progress with the Power of Data   In this series of stories, learn more about how cancer research data is being collected and used to improve the lives of people with cancer and their families. Drug Combination Leads to Long-Lasting Remissions in Hairy Cell Leukemia In a small study, two targeted therapies that are used separately to treat hairy cell leukemia were used together. The combination led to long-lasting remissions for most people with hairy cell leukemia that came back after treatment. Tumor Markers Learn about tumor markers. This updated page explains what they are and how they are used in cancer care. FDA Approvals New Treatment for Endometrial Cancer We've added a new drug summary for dostarlimab-gxly (Jemperli). This drug was recently approved by the Food and Drug Administration to treat certain adults with endometrial cancer that came back or spread after platinum chemotherapy.   Also of Interest Communication in Cancer Care Communication is important throughout cancer care. Learn how good communication between the person with cancer, caregivers, and the health care team can improve quality of life. Contact Us for Help Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892